Vision
AI-engineered vaccines unlocking new solutions for cancer treatment.
Vision
AI-engineered vaccines unlocking new solutions for cancer treatment.
Scientific Value Proposition
AI-Powered Personalized Cancer Therapy
Personalized cancer vaccines are changing how we fight cancer.
Tailored to each patient through AI, these vaccines are built to keep cancer from coming back.
What makes Neogenlogic’s AI powerful is its ability to rally the immune system’s full force —
activating killer T cells, helper T cells, and even B cells.
Backed by real research and clinical results, Neogenlogic’s AI is bringing tomorrow’s cancer treatment to patients today.
Neogenlogic's Core Leadership
Jung Kyoon Choi, PhD
CEO, Research & Development
- Professor at KAIST
- Ph.D. in Science, KAIST
- Director, SCL Science-KAIST Institute of Translational Research
- Member, Y-KAST (The Korean Academy of Science and Technology)
- Chief researcher, Genome Institute of Singapore (former)
Sangchul Kim, Esq
CEO, Corporate Strategy & Partnerships
- Vice President (CSO), SCL Science
- Head of Corporate Strategy Division, SCL
- Completed The College of Law of England & Wales
- Member, European Law Association
Pilnam Kim, PhD
CSO, Scientific Strategy & Innovation
- Professor at KAIST
- Ph.D. in Engineering, Seoul National University
- Senior Researcher, KIST (former)
- Research Fellow, Princeton University (former)
- Research Fellow, MIT (former)
Baik Sae-yun, MD
CMO, Clinical Development & Operations
- CEO, SCL Science
- MD in Medicine, Ajou University/BA in Medicine, Ewha Womans University
- Medical specialist in clinical pathology
- Head of Future Medicine Business Division, Hanaro Medical Foundation
- Medical Director, SCL Healthcare C-Lab
- Vice Director, GC Labs (former)
Chun-sik Yang
CFO, Financial Planning & Management
- Vice President (COO & CFO), SCL Science
- Head of Financial Strategy Office, SCL Holdings
- CEO, KT Skylife (former)
- Head of Business Planning (CFO/CSO), KT Skylife (former)